Study for treatment of colorectal cancer

Primary disease category: Cancer

Secondary disease categories: Colorectal Cancer

Sponsor: Southwest Oncology Group

Protocol number: N1048

Projected enrollment dates: January 2014 to June 2020

Official study title: A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision ** Pre-operative Radiation Or Selective Preoperative radiation and Evaluation before Chemotherapy and TME